Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kraft Foods Group, Inc. | 198,928 | reported | 06 Mar 2015 | tx 19+567,301−83,507 |
| Mondelez International, Inc. | 133,693 | reported | 17 Aug 2012 | tx 12+596,295−33,207 |
| Nuvation Bio Inc. | 123,397 | reported | 21 May 2026 | tx 11+1,832,112 |
| ULURU INC. | 100,000 | reported | 15 May 2008 | tx 2+100,000 |
| Axovant Sciences Ltd. | 70,000 | reported | 15 May 2017 | tx 2+123,937 |
| Intersect ENT, Inc. | 9,666 | reported | 04 Jun 2020 | tx 12+84,019 |
| NovoCure Ltd | 0 | reported | 28 Apr 2026 | tx 26+416,998−378,693 |
| MEDIVATION, INC. | 0 | reported | 28 Sept 2016 | tx 52+294,301−721,580 |
| MCCORMICK & CO INC | 0 | reported | 15 Feb 2026 | tx 36+45,128−11,113 |
| WHITEWAVE FOODS Co | 0 | reported | 12 Apr 2017 | tx 12+15,046−15,046 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Nuvation Bio Inc. | 123,397 | 0.00 USD | deriv |
| 28 Apr 2026 | EXERCISE | NovoCure Ltd | 21,500 | 11.39 USD | |
| 28 Apr 2026 | EXERCISE | NovoCure Ltd | 21,500 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | MCCORMICK & CO INC | 2,222 | — | |
| 15 Feb 2026 | EXERCISE | MCCORMICK & CO INC | 2,222 | — | deriv |
| 04 Jun 2025 | GRANT_AWARD | NovoCure Ltd | 11,215 | 0.00 USD | |
| 04 Jun 2025 | GRANT_AWARD | NovoCure Ltd | 16,697 | 0.00 USD | deriv |
| 03 Jun 2025 | SALE | NovoCure Ltd | 999 | 17.35 USD | |
| 21 May 2025 | GRANT_AWARD | Nuvation Bio Inc. | 292,983 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | MCCORMICK & CO INC | 1,344 | 0.00 USD | |
| 15 Mar 2025 | EXERCISE | MCCORMICK & CO INC | 1,344 | 0.00 USD | deriv |
| 07 Feb 2025 | GRANT_AWARD | MCCORMICK & CO INC | 2,222 | 0.00 USD | deriv |
| 03 Sept 2024 | GRANT_AWARD | Nuvation Bio Inc. | 200,801 | 0.00 USD | deriv |
| 04 Jun 2024 | SALE | NovoCure Ltd | 964 | 23.89 USD | |
| 05 Jun 2024 | GRANT_AWARD | NovoCure Ltd | 4,053 | 0.00 USD | |
| 05 Jun 2024 | GRANT_AWARD | NovoCure Ltd | 6,229 | 0.00 USD | deriv |
| 27 Mar 2024 | GRANT_AWARD | MCCORMICK & CO INC | 3,732 | 0.00 USD | deriv |
| 27 Mar 2024 | GRANT_AWARD | MCCORMICK & CO INC | 1,344 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | MCCORMICK & CO INC | 1,255 | — | |
| 15 Mar 2024 | EXERCISE | MCCORMICK & CO INC | 1,255 | 0.00 USD | deriv |
| 07 Jun 2023 | GRANT_AWARD | NovoCure Ltd | 3,853 | 0.00 USD | |
| 07 Jun 2023 | GRANT_AWARD | NovoCure Ltd | 6,277 | 0.00 USD | deriv |
| 15 May 2023 | GRANT_AWARD | Nuvation Bio Inc. | 366,744 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | MCCORMICK & CO INC | 1,255 | 0.00 USD | deriv |
| 29 Mar 2023 | GRANT_AWARD | MCCORMICK & CO INC | 3,101 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 17 Apr 2017.